We found association between high ratios of CD14+/CD16+ monocytes and acute infections, as in AA, MA and SA, while those ratios normalized in recovered patients (AP, MP, MR, and SR), but persistently high CD14+/CD16+ monocyte ratios were associated with development of severe COVID-19 in SP (Figure 3C). This evidence concerns the gene CD14 and COVID-19.